Recent Articles

Johnson & Johnson (JNJ) Testing Type 1 Diabetes Cure

Johnson & Johnson is teaming up with ViaCyte to test a cure for Type 1 Diabetes that replaces missing insulin-producing cells with new ones. More 

5 New Stocks to Watch: Can IPOs Get Their Groove Back?

It's been a horrendous start for new stocks so far, but this week could see the year's first deals. More 

The 10 Best Healthcare Stocks to Buy Now

This list of the 10 best healthcare stocks to buy now includes extremely well-capitalized companies paying extraordinary dividends ... and trading for cheap. More 

JNJ News: What to Know About Johnson & Johnson Q4 Earnings

Johnson & Johnson has released its earnings report for the fourth quarter of 2015 and its shares were up 2% Tuesday morning. More 

81 Ways to Make Market Swings Work for You

During these times it pays to stay on top of profit opportunities. Today's blog post is a great place to start with these updated rankings More 

3 Dividend Stocks To Buy Now And Hold Forever

With the S&P 500 down you can't be blamed for wanting to sell all your stocks. Don't! Look at these 3 dividend stocks to buy for the long term. More 

2 Trades for Johnson & Johnson (JNJ) Stock Ahead of Earnings

JNJ stock holders eye restructuring moves as Johnson & Johnson readies its fourth-quarter earnings release. More